Ineffective erythropoiesis and its treatment.
Cazzola M.
Blood. 2022 Apr 21;139(16):2460-2470. doi: 10.1182/blood.2021011045.
Ineffective Erythropoiesis: Anemia and Iron Overload.
Gupta R, Musallam KM, Taher AT, Rivella S.
Hematol Oncol Clin North Am. 2018 Apr;32(2):213-221. doi: 10.1016/j.hoc.2017.11.009. Epub 2017 Dec 29.
Hereditary disorders of ineffective erythropoiesis.
King RA, Khoriaty R.
Blood Cells Mol Dis. 2025 Mar;111:102910. doi: 10.1016/j.bcmd.2025.102910. Epub 2025 Feb 7.
Luspatercept: a treatment for ineffective erythropoiesis in thalassemia.
Musallam KM, Taher AT.
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):419-425. doi: 10.1182/hematology.2024000567.
Ineffective Erythropoiesis in beta-Thalassaemia: Key Steps and Therapeutic Options by Drugs.
Longo F, Piolatto A, Ferrero GB, Piga A.
Int J Mol Sci. 2021 Jul 5;22(13):7229. doi: 10.3390/ijms22137229.
New insights into erythropoiesis: the roles of folate, vitamin B12, and iron.
Koury MJ, Ponka P.
Annu Rev Nutr. 2004;24:105-31. doi: 10.1146/annurev.nutr.24.012003.132306.
[Ineffective erythropoiesis in myelodysplastic syndrome].
Iwama A.
Rinsho Ketsueki. 2018;59(6):793-797. doi: 10.11406/rinketsu.59.793.
Pathogenic Mechanisms in Thalassemia I: Ineffective Erythropoiesis and Hypercoagulability.
Bou-Fakhredin R, Rivella S, Cappellini MD, Taher AT.
Hematol Oncol Clin North Am. 2023 Apr;37(2):341-351. doi: 10.1016/j.hoc.2022.12.005.
Ineffective erythropoiesis in sickle cell disease: new insights and future implications.
El Nemer W, Godard A, El Hoss S.
Curr Opin Hematol. 2021 May 1;28(3):171-176. doi: 10.1097/MOH.0000000000000642.
Ineffective erythropoiesis and osteoporosis in thalassemia: Mechanistic insights?
Means RT Jr.
Am J Med Sci. 2023 Aug;366(2):85-86. doi: 10.1016/j.amjms.2023.05.001. Epub 2023 May 4.
